Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 1,404 | 0 | 0 | 0 |
| Gross Profit | N/A | 1,404 | N/A | N/A | N/A |
| Operating Expenses | 724 | 1,107 | 1,905 | 1,596 | 3,156 |
| Operating Income | -724 | 297 | -1,905 | -1,596 | -3,156 |
| Other Income | 32 | 32 | 47 | 37 | 69 |
| Pre-tax Income | -692 | 329 | -1,858 | -1,559 | -3,087 |
| Net Income Continuous | -692 | 329 | -1,858 | -1,559 | -3,087 |
| Minority Interests | -9 | -6 | -6 | -15 | -11 |
| Net Income | $-683 | $335 | $-1,852 | $-1,544 | $-3,076 |
| EPS Basic Total Ops | -0.21 | 0.11 | -0.62 | 7.96 | -1.92 |
| EPS Basic Continuous Ops | -0.22 | 0.10 | -0.63 | 3.05 | -1.93 |
| EPS Diluted Total Ops | -0.21 | 0.11 | -0.62 | 7.96 | -1.92 |
| EPS Diluted Continuous Ops | -0.22 | 0.10 | -0.63 | 3.05 | -1.93 |
| EPS Diluted Before Non-Recurring Items | -0.21 | 0.11 | -0.62 | 1.48 | -1.92 |
| EBITDA(a) | $-724 | $297 | $-1,905 | $-1,596 | $-3,156 |